NeuMoDx Molecular, Inc. operates as a molecular diagnostics company. The company develops solutions for molecular diagnostic (MDx) testing
NeuMoDx Molecular, Inc. operates as a molecular diagnostics company. The company develops solutions for molecular diagnostic (MDx) testing in hospital and clinical reference laboratories.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 3, 2018 | Series Unknown | $20.03M | — | — | — | Detail |
| Apr 29, 2016 | Series Unknown | $19.99M | — | — | — | Detail |
| Apr 1, 2014 | Series B | $21M | 5 |
Baird Capital
Pfizer Venture Investments
Venture Investors
|
— | Detail |
| Apr 1, 2012 | Series A | $5M | 1 |
Wolverine Venture Fund
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Baird Capital
|
Yes | Series B |
Pfizer Venture Investments
|
Yes | Series B |
Venture Investors
|
Yes | Series B |
Arboretum Ventures
|
— | Series B |
Wolverine Venture Fund
|
— | Series B |